These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma TSH and serum T-4 levels in long-term follow-up of patients treated with 131-I for thyrotoxicosis. Toft AD; Irvine WJ; Hunter WM; Seth J Br Med J; 1974 Jul; 3(5924):152-3. PubMed ID: 4136163 [TBL] [Abstract][Full Text] [Related]
3. Thyroid function in patients treated with radioactive iodine for thyrotoxicosis. Tunbridge WM; Harsoulis P; Goolden AW Br Med J; 1974 Jul; 3(5923):89-92. PubMed ID: 4855207 [TBL] [Abstract][Full Text] [Related]
4. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis. Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396 [No Abstract] [Full Text] [Related]
5. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism. Price DE; O'Malley BP; Northover B; Rosenthal FD Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141 [TBL] [Abstract][Full Text] [Related]
6. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis. Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033 [No Abstract] [Full Text] [Related]
7. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine. Davies PH; Franklyn JA; Daykin J; Sheppard MC J Clin Endocrinol Metab; 1992 May; 74(5):1189-94. PubMed ID: 1569166 [TBL] [Abstract][Full Text] [Related]
8. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs. Peterson ME; Melián C; Nichols R J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888 [TBL] [Abstract][Full Text] [Related]
9. Serum triiodothyronine 7-15 years after fractionated low dose radioiodine therapy of thyrotoxicosis. Herrmann J; Schaps D; Rusche HJ; Berger M; Krüskemper HL; von zur Hühlen A; Hackenberg K; Reinwein D Clin Endocrinol (Oxf); 1975 Mar; 4(2):205-12. PubMed ID: 48437 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of radioiodine (131I) therapy in 331 patients with Graves' disease. Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K Tohoku J Exp Med; 1980 Sep; 132(1):1-10. PubMed ID: 6894205 [TBL] [Abstract][Full Text] [Related]
11. Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis. Toft AD; Irvine WJ; Seth J; Hunter WM; Cameron EH Lancet; 1975 Sep; 2(7935):576-8. PubMed ID: 51406 [TBL] [Abstract][Full Text] [Related]
12. How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis? Toft AD; Irvine WJ; Seth J; Cameron EH Br Med J; 1978 Oct; 2(6145):1115-7. PubMed ID: 709256 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)]. Glanzmann Ch; Horst W Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268 [TBL] [Abstract][Full Text] [Related]
14. [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine]. Schrub JC; Nouel JP; Brunelle P; Segond G; Courtois H; Poirier A Nouv Presse Med; 1976 May; 5(21):1346-8. PubMed ID: 778789 [TBL] [Abstract][Full Text] [Related]